AI reads MRI scans to predict who will beat rectal cancer

NCT ID NCT05523245

Recruiting now Knowledge-focused Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing whether an artificial intelligence (AI) system can analyze MRI scans to predict how well rectal cancer responds to chemotherapy and radiation before surgery. Researchers will enroll 1,700 adults with locally advanced rectal cancer. The goal is to help doctors decide the best treatment plan for each patient.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RECTAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

rectal cancer rectal neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

RECTAL CANCER

Contacts and locations

Locations

Fifth Affiliated Hospital, Sun Yat-sen University
NOT_YET_RECRUITING

Zhuhai, Guangdong, China
Sixth Affiliated Hospital, Sun Yat-sen University
RECRUITING

Guangzhou, Guangdong, China
The First Affiliated Hospital of Jinan University
NOT_YET_RECRUITING

Guangzhou, Guangdong, China
The Second Affiliated Hospital of Guangzhou Medical University
NOT_YET_RECRUITING

Guangzhou, Guangdong, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.